Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells

Blood

Volumn 84, Issue 2, 1994, Pages 380-383

  Rill, Donna R ^b   Santana, Victor M ^b   Roberts, W Mark ^b   Nilson, Terri ^b   Bowman, Laura C ^b   Krance, Robert A ^b   Heslop, Helen E ^b   Moen, Robert C ^b   Ihle, James N ^b   Brenner, Malcolm K ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER RECURRENCE; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MARKER GENE; MELANOMA; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0028263529     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v84.2.380.380     Document Type: Article

References (19)

1. Peters WP: Autologous bone marrow transplantation for breast cancer. Curr Opin Oncol 4:279, 1992
2. Mulder PO, Sleijfer DT, Willemse PH, de Vries EG, Uges DR, Mulder NH: High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors. Cancer Res 49:4654, 1989
3. Graham-Pole J, Casper J, Elfenbein G, Gee A, Gross S, Janssen W, Koch P, Marcus R, Pick T, Shuster J, Spruce W, Thomas P, Yeager A: High-dose chemotherapy supported by marrow infusions for advanced neuroblastoma: A Pediatric Oncology Group Study. J Clin Oncol 9:152, 1991
4. Waldrop MM: Purging cancer from the bone marrow. Science 248:816, 1990
5. Armitage JO, Gale RP: Bone marrow autotransplantation. Am J Med 86:203, 1989
6. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Carol F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
7. Shpall EJ, Jones RB, Bast RC Jr, Rosner GL, Vandermark R, Ross M, Affronti ML, Johnston C, Eggleston S, Tepperburg M, Coniglio D, Peters WP: 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: A phase I trial. J Clin Oncol 9:85, 1991
8. Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsay NKC: Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N Engl J Med 329:1296, 1993
9. Yeager AM, Kaizer H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH: Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 315:141, 1986
10. Rill DR, Moen RC, Buschle M, Bartholomew C, Foreman NK, Mirro J Jr, Krance RA, Ihle JN, Brenner MK: An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood 79:2694, 1992
11. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341:85, 1993
12. Rill DR, Buschle M, Foreman NK, Bartholomew C, Moen RC, Santana VM, Ihle JN, Brenner MK: Retrovirus mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation. Hum Gene Ther 3:129, 1992
13. Bender MA, Palmer TD, Gelinas RE, Miller AD: Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol 61:1639, 1987
14. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW: Survival and retrovirus infection of murine hematopoietic stem cells in vitro: Effects of 5-FU and method of infection. Exp Hematol 19:206, 1991
15. Triglia T, Peterson MG, Kemp DJ: A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences. Nucleic Acids Res 16:8186, 1988
16. Ochman HA, Gerber S, Hart DL: Genetic application of an inverse polymerase chain reaction. Genetics 120:621, 1988
17. Ch'ng JL, Mulligan RC, Schimmel P, Holmes EW: Antisense RNA complementary to 3′ coding and noncoding sequences of creatine kinase is a potent inhibitor of translation in vivo. Proc Natl Acad Sci USA 86:10006, 1989
18. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
19. Graham-Pole J, Gee A, Emerson S, Gallo J, Lee C, Luzins J, Janssen WE, Pick T, Worthington-White D, Elfenbein G, Gross S, Weiner R: Myeloablative chemoradiotherapy and autologous bone marrow infusions for treatment of neuroblastoma: Factors influencing engraftment. Blood 78:1607, 1991